Search
for
Sort by
Research 721–750 of 1000+
- The Pharmacokinetics of 2.5- to 10-mg Oral Doses of Minoxidil in Healthy Volunteers
- The Implication of Neuroactive Steroids in Tourette's Syndrome Pathogenesis: A Role for 5α‐Reductase?
- Inhibition of 5α-Reductase Activity in SZ95 Sebocytes and HaCaT Keratinocytes <i>In Vitro</i>
- Finasteride: The First 5α-Reductase Inhibitor
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Analysis of the microRNA expression profile of normal human dermal papilla cells treated with 5α-dihydrotestosterone
- Twice weekly 5 mg betamethasone oral pulse therapy in the treatment of alopecia areata
- Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana
- Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
- Synthesis of 5,6,6-[2H3]finasteride and quantitative determination of finasteride in human plasma at picogram level by an isotope-dilution mass spectrometric method
- Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis
- Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol kinase 5
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- Possible involvement of 5α-reduced neurosteroids in adrenergic and serotonergic stimulation of GFAP gene expression in rat C6 glioma cells
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice
- Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles
- N-(3,5-Dimethylphenyl)-3-Methoxybenzamide (A3B5) Targets TRP-2 and Inhibits Melanogenesis and Melanoma Growth
- Extramammary Paget disease: Failure to respond to topical imiquimod 5%
- New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide)
- Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men
- Label-free concurrent 5-modal microscopy (Co5M) resolves unknown spatio-temporal processes in wound healing
- 3,4,5-Tri-O-Caffeoylquinic Acid Promoted Hair Pigmentation Through β-Catenin and Its Target Genes
- CRISPR/Cas9-mediated Disruption of Fibroblast Growth Factor 5 in Rabbits Results in a Systemic Long Hair Phenotype by Prolonging Anagen
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss
- Syphilitic Alopecia: A Report of 5 Cases and a Review of the Literature
- Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model
- Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
- Finasteride: a 5 alpha-reductase inhibitor.